Guide detail

GLOW Protocol: BPC-157, TB-500, and GHK-Cu

This protocol provides a structured approach to safely and effectively use the peptide combination of BPC-157 (for tissue repair), TB-500 (for muscle and tendon recovery), and GHK-Cu (for skin rejuvenation and collagen synthesis). The peptides work synergistically to enhance healing and recovery.

  1. Preparation: Gather all necessary supplies, including sterile bacteriostatic water, insulin syringes (29-31 gauge), alcohol swabs, and a sharps container.

  2. Reconstitution:

    • BPC-157: Reconstitute 5mg vial with 2.5ml bacteriostatic water (yielding 200mcg per 0.1ml).
    • TB-500: Reconstitute 5mg vial with 2.5ml bacteriostatic water (yielding 200mcg per 0.1ml).
    • GHK-Cu: Reconstitute 50mg vial with 2.5ml bacteriostatic water (yielding 2mg per 0.1ml).
  3. Storage: Store reconstituted peptides in the refrigerator (2-8°C) and use within 21 days.

  4. Dosage and Administration:

    • BPC-157: 250-500mcg per day, split into 1-2 subcutaneous (SubQ) or intramuscular (IM) injections near the injury site (if applicable).
    • TB-500: 500-1000mcg per week, split into 2 SubQ injections (e.g., 250mcg twice weekly).
    • GHK-Cu: 2-4mg per day, administered as a single SubQ injection or topical application (if skin benefits are desired).
  5. Cycle Length: Run the combination for 4-6 weeks, followed by a 2-week break to assess tolerance and effects.

  6. Injection Technique: Clean the injection site with an alcohol swab, pinch the skin, insert the needle at a 45-90° angle, inject slowly, and dispose of the syringe safely.

  7. Monitoring: Track progress, side effects, and adjust dosages if necessary under professional guidance. - Rotate injection sites to avoid tissue irritation.,- BPC-157 and TB-500 are best used for acute injuries or chronic recovery; GHK-Cu is more systemic and supports skin/anti-aging.,- Topical GHK-Cu can be applied directly to the skin (e.g., in serums) for localized benefits.,- Consult a healthcare provider before starting, especially if you have pre-existing conditions.

Warnings

  • Do not exceed recommended dosages; peptides are potent and can cause unintended effects.
  • Avoid intravenous (IV) injection; peptides must be administered SubQ or IM.
  • Discontinue use if severe irritation, allergic reactions, or unusual symptoms occur.
  • Not for use during pregnancy or breastfeeding.
  • Peptides may interact with other medications; disclose all supplements/drugs to your doctor.

References

  • BPC-157: Therapeutic potential in wound healing and organ protection (Sikiric et al., 2014).
  • TB-500: Mechanisms in actin regulation and tissue repair (Goldberg et al., 2016).
  • GHK-Cu: Role in collagen synthesis and anti-aging (Pickart et al., 2015).